Back to search

Switzerland· 69111002

Vildagliptin Sandoz 50 mg, Tabletten

A vildagliptin product containing vildagliptinum, registered in Switzerland by Sandoz Pharmaceuticals AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A10BH02

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVildagliptin Sandoz 50 mg, TablettenATCA10BH02REGISTER NO.69111002PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Vildagliptin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BH02 (vildagliptin), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Vildagliptin · ATC A10BH02

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vildagliptin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), the median price runs from $0.32 in France to $1.98 in Switzerland — a ×6.2 gap.

  • Switzerland: $1.98 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Vildagliptin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.98
  • IT Italy$1.0
  • FR France$0.32
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
vildagliptinum
Manufacturer
Sandoz Pharmaceuticals AG
Country
Switzerland (CH)
ATC code
A10BH02
ATC class
Vildagliptin
Defined daily dose
0.1 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680691110023
    Blist 112 Stk
    CHF 61.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Vildagliptin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vildagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Melkart, Saxotin
  • Belgium · Vildagliptin Krka
  • Bulgaria · Глипвило, Далмевин
  • Cyprus · Aglimon, Dalmevin
  • Czechia · Alikval, Anvildis
  • Germany · Vildabetes, Vildagliptin Al
  • Denmark · Vildagliptin "a. E. Tiefenbacher", Vildagliptin "axunio"
  • Estonia · Dalmevin, Glypvilo
  • Spain · Vildagliptina, Vildagliptina Alter
  • Finland · Vildagliptin Krka, Vildagliptin Ratiopharm
  • France · Vildagliptine Accord, Vildagliptine Arrow
  • United Kingdom (Northern Ireland) · Vildagliptin, Vildagliptin Accord-Uk
  • Greece · Dalmevin, Varbos
  • Croatia · Agnis, Dalmevin
  • Hungary · Agartha, Alikval
  • Ireland · Vildagliptin Krka
  • Iceland · Galvus, Jalra
  • Italy · Vildagliptin Accord, Vildagliptin Aurobindo
  • Liechtenstein · Galvus, Jalra
  • Lithuania · Dalmevin, Glypvilo
  • Latvia · Dalmevin, Glypvilo
  • Malta · Alikval, Dalmevin
  • Netherlands · Vilanov, Vildagliptine Accord
  • Norway · Galvus, Jalra
  • Poland · Anvildis, Diptivil
  • Portugal · Tutecvi, Vezagla
  • Romania · Agartha, Dalmevin
  • Sweden · Dalmevin, Kwikaton
  • Slovenia · Glypvilo
  • Slovakia · Anvildis, Dalmevin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d044f3ac-d6a2-445b-8196-a215e92a83ea
GET /v1/drugs/d044f3ac-d6a2-445b-8196-a215e92a83ea?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "vildagliptinum 50 mg",
  "valid_from": "2023-06-01",
  "limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, wenn Diät und körperlicher Bewegung nicht ausreichen: <br>\\n- Als Monotherapie, für Patienten, welche mit den bisherigen oralen Therapien nur ungenügend eingestellt werden können oder diese nicht vertragen.<br>\\n- Als Zweifachkombination mit folgenden Therapieoptionen, wenn mit diesen Behandlungen keine ausreichende Kontrolle der Glykämie erreicht werden kann:<br>\\n&nbsp;    - mit Metformin oder<br>\\n&nbsp;    - mit einem Sulfonylharnstoff (SU) oder<br>\\n&nbsp;    - mit Thiazolidindione (TZD)<br>\\n- Als Dreifachkombination mit Metformin und einem Sulfonylharnstoff, wenn mit der Zweifachkombination mit diesen Substanzen keine ausreichende Kontrolle der Glykämie erreicht werden kann.<br>\\n- In Kombination mit Insulin (mit oder ohne Metformin), wenn mit einer stabilen Dosis Insulin keine ausreichende Kontrolle der Glykämie erreicht werden kann.<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2023-12-01\"}]",
  "galenic_form": "Tabl 50 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2023-06-01",
  "self_retention_pct": 10
}

See everything about vildagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.